India to get 5 more COVID-19 vaccines by October; Sputnik expected to get emergency use nod in 10 days

As more and more states flag shortage of COVID19 vaccine doses the Central government has pressed the accelerator to scale up vaccine production manifoldTop government sources told ANI that by end of the third quarter of this year India will be getting vaccines from five additional manufacturers India currently manufactures Covishield and CovaxinExplaining the new strategy to manufacture additional vaccine doses a source said India currently has 2 COVID19 vaccines being manufactured locally Covishield and Covaxin and we can expect five more vaccines by Q3 2021 These vaccines are Sputnik V vaccine in collaboration with Dr Reddys Johnson amp Johnson vaccine in collaboration with Biological E Novavax vaccine in collaboration with Serum India Zydus Cadilas vaccine and Bharat Biotechs Intranasal Vaccine Safety and efficacy are the Union governments primary concerns while granting emergency use authorisation EUA to any COVID19 vaccine in the countryOut of almost 20 COVID19 vaccines in various clinical and preclinical stages Sputnik V vaccine will get the nod first It is expected that Sputnik is likely to get the EUA within the next ten daysRussian Direct Investment Fund RDIF has tied up with a host of Indian pharmaceutical players such as Hyderabad based Dr Reddys Laboratories Hetero Biopharma Gland Pharma Stelis Biopharma and Vichrow Biotech for the production of vaccine doses With a production capacity of 850 million doses in the country Sputnik V will provide a major shot in the arm in the fight against COVID19When asked from a toplevel source when will the vaccines be available for use he said Sputnik is expected to be available latest by June if all goes well Johnson and Johnson Bio E will be available by August Cadilla Zydus will also be available by August Novavex Serum by September and Nasal Vaccine Bharat by OctoberThe Government is making all efforts to accelerate the progress without cutting any corners in research development and clinical trial stages the source addedThe government is taking all steps to augment vaccine production and availability in India A decision has been taken at the highest level to ensure all steps are taken to help domestic manufacturers to scale up vaccine production manifoldThe Government of India is determined to ensure India remains the pharmacy of the world and Indians have equitable access to the highest quality vaccines in the world We encourage all COVID19 vaccine manufacturers to come to India as the Central Government is ready to provide manufacturing assistance financial support and partnership in running and designing clinical trials sources addedIndia is currently facing the second wave of COVID19 pandemic with the number of new cases increasing each dayThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever